Gastroenterology April 2026 Faecalibacterium prausnitzii Induces an Anti-inflammatory Response and a Metabolic Reprogramming in Human Monocytes

This study explores how a common gut bacterium, Faecalibacterium prausnitzii, protects human health by directly influencing immune cells to reduce inflammation. Researchers discovered that this specific microbe triggers a dose-dependent production of IL10, a vital anti-inflammatory signal, within monocytes located in both the blood and the intestines. Unlike other bacteria, F. prausnitzii achieves this effect by rewiring the metabolic pathways of these cells, specifically by shifting their reliance toward mitochondrial respiration. By providing a mechanistic explanation for how this bacterium stabilizes the immune system, the text highlights its potential as a therapeutic tool for treating inflammatory bowel disease